The efficacy and safety of palonosetron compared with granisetron in preventing highly emetogenic chemotherapy-induced vomiting in the Chinese cancer patients: a phase II, multicenter, randomized, double-blind, parallel, comparative clinical trial

Author： Yu Zhaocai  

Publisher： Springer Publishing Company

ISSN： 0941-4355

Source： Supportive Care in Cancer, Vol.17, Iss.1, 2009-01, pp. : 99-102

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Randomized, double-blind, crossover study of palonosetron compared with granisetron for the prevention of chemotherapy-induced nausea and vomiting in a Chinese population

By Tian Weihua  

Medical Oncology, Vol. 28, Iss. 1, 2011-03 ,pp. : 71-78

Humana Press, Inc

Access to resources Recommend Favorite

Effectiveness of palonosetron for preventing delayed chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy in patients with gastrointestinal cancer

By Murakami Michiyasu   Hashimoto Hiroki   Yamaguchi Kyohei   Yamaguchi Ikuko   Senba Shozo   Siraishi Takeshi  

Supportive Care in Cancer, Vol. 22, Iss. 4, 2014-04 ,pp. : 905-909

Springer Publishing Company

Access to resources Recommend Favorite

Aprepitant triple therapy for the prevention of chemotherapy-induced nausea and vomiting following high-dose cisplatin in Chinese patients: a randomized, double-blind, placebo-controlled phase III trial

By Hu Zhihuang   Cheng Ying   Zhang Hongyu   Zhou Caicun   Han Baohui   Zhang Yiping   Huang Cheng   Chang Jianhua   Song Xiangqun   Liang Jun   Liang Houjie   Bai Chunxue   Yu Shiying   Chen Jia   Wang Jie   Pan Hongming   Chitkara Denesh   Hille Darcy   Zhang Li  

Supportive Care in Cancer, Vol. 22, Iss. 4, 2014-04 ,pp. : 979-987

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy and safety of single-dose fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving high-dose cisplatin: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial

By Saito H.   Yoshizawa H.   Yoshimori K.   Katakami N.   Katsumata N.   Kawahara M.   Eguchi K.  

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 1067-1073

Oxford University Press

Access to resources Recommend Favorite

A double-blind, crossover, randomized dose-comparison trial of granisetron for the prevention of acute and delayed nausea and emesis in children receiving moderately emetogenic carboplatin-based chemotherapy

By Berrak Su  

Supportive Care in Cancer, Vol. 15, Iss. 10, 2007-10 ,pp. : 1163-1168

Springer Publishing Company

Access to resources Recommend Favorite